Page last updated: 2024-08-21

paraquat and atorvastatin

paraquat has been researched along with atorvastatin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khoramjouy, M; Malekinejad, H; Mehrabi, M; Rezaei-Golmisheh, A1
Amniattalab, A; Hobbenaghi, R; Khoramjouy, M; Malekinejad, H1
Alizadeh-Tabrizi, N; Cheraghi, H; Malekinejad, H; Varasteh, S1
Du, J; Meng, X; Wang, J; Wang, R; Xie, H; Zhou, Z; Zhu, Y1
Alenabi, A; Hallaj-Salahipour, M; Khoramjouy, M; Malekinejad, H; Malekinejad, M; Masoumi Verki, M1
Buendía, JA; Justinico Castro, JA; Sánchez Villamil, JP; Sinisterra, D; Vela, LJT; Zuluaga Salazar, AF1

Other Studies

6 other study(ies) available for paraquat and atorvastatin

ArticleYear
Antifibrotic effect of atorvastatin on paraquat-induced pulmonary fibrosis: role of PPARγ receptors.
    European journal of pharmacology, 2013, Nov-15, Volume: 720, Issue:1-3

    Topics: Anilides; Animals; Atorvastatin; Body Weight; Heptanoic Acids; Herbicides; Hydroxyproline; Lung; Male; Organ Size; Paraquat; Pioglitazone; PPAR gamma; Protective Agents; Pulmonary Fibrosis; Pyrroles; Rats; Rats, Wistar; RNA, Messenger; Thiazolidinediones; Transforming Growth Factor beta1

2013
Atorvastatin attenuates the paraquat-induced pulmonary inflammation via PPARγ receptors: a new indication for atorvastatin.
    Pesticide biochemistry and physiology, 2014, Volume: 114

    Topics: Animals; Anti-Inflammatory Agents; Atorvastatin; Heptanoic Acids; Herbicides; Interleukin-6; Lung; Male; Malondialdehyde; Nitric Oxide; Paraquat; Peroxidase; Pioglitazone; Pneumonia; PPAR gamma; Pyrroles; Rats, Wistar; Thiazolidinediones; Tumor Necrosis Factor-alpha; Weight Loss

2014
Atorvastatin protected from paraquat-induced cytotoxicity in alveolar macrophages via down-regulation of TLR-4.
    Environmental toxicology and pharmacology, 2017, Volume: 49

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Atorvastatin; Cell Survival; Cells, Cultured; Down-Regulation; Herbicides; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macrophages, Alveolar; Male; Nitric Oxide; Paraquat; Peroxidase; Rats; Toll-Like Receptor 4

2017
Atorvastatin attenuates paraquat poisoning-induced epithelial-mesenchymal transition via downregulating hypoxia-inducible factor-1 alpha.
    Life sciences, 2018, Nov-15, Volume: 213

    Topics: A549 Cells; Animals; Atorvastatin; Cadherins; Cell Line; Epithelial-Mesenchymal Transition; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Lung; Lung Injury; Male; Paraquat; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Signal Transduction; Zonula Occludens-1 Protein

2018
Cardioprotective Effects of Atorvastatin Are Mediated Through PPARγ in Paraquat-Exposed Rats.
    Journal of cardiovascular pharmacology, 2019, Volume: 74, Issue:5

    Topics: Animals; Antioxidants; Atorvastatin; Cardiotoxicity; Creatine Kinase, MB Form; Cyclooxygenase 2; Disease Models, Animal; Heart Diseases; Lipid Peroxidation; Male; Myocytes, Cardiac; Nitric Oxide; Oxidative Stress; Paraquat; Peroxidase; PPAR gamma; Rats, Wistar; Signal Transduction; Sulfhydryl Compounds

2019
Comparison of four pharmacological strategies aimed to prevent the lung inflammation and paraquat-induced alveolar damage.
    BMC research notes, 2019, Sep-18, Volume: 12, Issue:1

    Topics: Animals; Antioxidants; Ascorbic Acid; Atorvastatin; Cyclophosphamide; Dexamethasone; Drug Therapy; Drug Therapy, Combination; Heparin; Heparin, Low-Molecular-Weight; Lung; Paraquat; Pneumonia; Pulmonary Alveoli; Pulmonary Fibrosis; Rats, Wistar; Treatment Outcome

2019